Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Treatment of gastrointestinal bleeding in patients with severe von Willebrand disease by administration of recombinant VWF

Treatment of gastrointestinal bleeding in patients with severe von Willebrand disease by administration of recombinant VWF

US Patent 11529395 · Granted Dec 20, 2022

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Use of ADAMTS13 for treating, ameliorating and/or preventing vaso-occlusive cris2024
Methods of prophylactic treatment using recombinant VWF (rVWF)2024
Treatment of gastrointestinal bleeding in patients with severe von Willebrand di2024
Treatment of gastrointestinal bleeding in patients with severe von Willebrand di2024
Treatment of gastrointestinal bleeding in patients with severe von Willebrand di2024
Use of ADAMTS13 for treating, ameliorating and/or preventing vaso-occlusive cris2021
Treatment of gastrointestinal bleeding in patients with severe von Willebrand di2021
Treatment of gastrointestinal bleeding in patients with severe von Willebrand di2021
Treatment of gastrointestinal bleeding in patients with severe von Willebrand di2021
Treatment of gastrointestinal bleeding in patients with severe von Willebrand di2020
Treatment of gastrointestinal bleeding in patients with severe von Willebrand di2020
Treatment of gastrointestinal bleeding in patients with severe von Willebrand di2020